ISPOR Europe 2025
9-12 November
Program Committee
Say “hello” to the ISPOR Europe 2025 Program Committee! ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to attendees.
Co-Chairs
Maria Dutarte
Executive Director, European Patients’ Academy on Therapeutic Innovation (EUPATI), the Netherlands
Denise Lacombe, MD, MSc
Chief Executive Officer, European Organization for Research and Treatment of Cancer (EORTC), Belgium
Joep Muijrers, PhD
General Partner, Public Investments, Gilde Healthcare Partners, the Netherlands
Members
Bryan Bennett, PhD
Head of Patient Centered Outcomes, Senior Director, Jazz Pharma, United Kingdom
Sofie Berghuis, PhD
Market Access Director, GSK, the Netherlands
Imre Boncz, MD, MSc, PhD, Habil
Professor & Director, University of Pécs, Hungary
Thor-Henrik Brodtkorb, PhD
Executive Director, Health Economics, RTI Health Solutions, Sweden
Bill Byrom, PhD
Vice President, Product Intelligence and Positioning, Signant Health, United Kingdom
Koen Degeling, PhD, MSc, BSc
Senior Market Access Manager, GSK, the Netherlands
Lorna Dunning, MSc, MPH
Associate Director – Technology Appraisals, NICE, United Kingdom
Gihan Hamdy El-sisi
Managing Director, HTA Office (Technology Appraisal), Middle East and North Africa, Egypt
Rita Faria
Lead Health Economics, Astellas Pharma Europe Ltd, United Kingdom
Carla Fernández-Barceló, BSc, MPH
Senior Health Economics Consultant, Coreva Scientific GmbH & Co KG & Technical Officer for the Early Career Network Interest Group, Health Technology Assessment International, Germany
Kirk Geale, PhD
CEO and Board Member, Quantify Research, Sweden
Marieke Heisen
Director of Research and Patient Evidence, Patvocates & European Patient Advocacy Institute (EPAI), the Netherlands
Anke-Peggy Holtorf , MBA
Managing Director, Health Outcomes Strategies, Switzerland
Kirsten Janke, PhD
Research Associate, IQWiG, Germany
Seamus Kent, MSc, PhD
Assistant Professor, Erasmus University Rotterdam, the Netherlands
Irina Kinchin, MSc, PhD
Research Assistant Professor, Trinity College Dublin, Ireland
Katarzyna Kolasa, PhD
Director Digital Health Center, Professor of Health Economics, Kozminski University, Poland
Dawn Lee, MSc MMath
Associate Professor, PenTAG, University of Exeter, United Kingdom
Ka Keat Lim, MPharm, MSc, PhD
Lecturer in Health Economics, Queen Mary University of London, United Kingdom
Olena Mandrik
Senior Research Fellow, Sheffield Centre for Health and Related Research (SCHARR), School of Medicine and Population Health, The University of Sheffield, United Kingdom
Borislava Mihaylova
Professor of Health Economics, Health Economics and Policy Research Unit, Wolfson Institute of Population Health, Queen Mary University of London, United Kingdom & Senior Health Economist, Health Economics Research Centre, University of Oxford, United Kingdom
Oresta Piniazhko, PhD
Director of HTA Department, SEC of Ministry of Health of Ukraine, Ukraine
Thomas Rapp, PhD
Professor, Université Paris Cité (LIRAES), Co-director of the Health Policy Research Program, Sciences Po (LIEPP), Senior Advisor, Cepton-Vintura, France
Katja Rudell, BSc, MSc, PhD
Vice President, Kielo Research, United Kingdom
Fatima Salih, MSc
Scientific Advisor, NICE, United Kingdom
Delphine Saragoussi, MD, MScPH
Head of Pharmacoepidemiology - Vaccines, Patient Safety & Pharmacovigilance, Sanofi, France
Anne Spencer
Professor, University of Exeter, United Kingdom
Praveen Thokala, MASc, PhD
Director, PT Health Economics Ltd, United Kingdom
Sheela Upadhyaya
Life Sciences Consultant - Rare Diseases, Openflex Ltd, United Kingdom
Leonor Varela
Professor, Public Health and Preventive Medicine, University of Santiago de Compostela, Spain
Yves Verboven, MSc, Ir
Founder, EU4HealthSolutions, Executive in Residence, Vlerick Business School, Belgium
Steffen Wahler, MD
CEO, St. Bernward GmbH, Germany
Olivia Wu, FRSE, PhD, MSc
Professor, Health Economics and Health Technology Assessment (HEHTA) Research Group, University of Glasgow, United Kingdom